SELENOF and colonic neoplasm: TXNRD1, TXNRD3, SeP15, and SepX1 were associated with survival after colon cancer diagnosis; SeP15 and SepX1 remained significant after FDR multiple comparison adjustment (HRR 1.47, 95% CI 1.13,1.90 and HRR 1.47 95% CI 1.3,1.90 respectively).